Dear Colleagues,

It is a great pleasure to welcome you to the 4th International Electronic Conference on Cancers (IECC 2024), which will be held from 6 to 8 March 2024. The conference is organized by the MDPI open-access journal Cancers (Impact Factor 5.2). It allows scientists from all over the world to present their latest research in Cancers, receive direct feedback, and engage in discussions with the wider scientific community.

In recent years, we have witnessed remarkable breakthroughs in basic cancer research, where discoveries in the genetic and epigenetic tumor make-up and tumor microenvironment have provided valuable insights into the molecular mechanisms underlying cancer initiation, progression, and therapeutic response. This newfound knowledge has laid the groundwork for novel treatment strategies and personalized approaches that hold the potential to revolutionize cancer care. This conference aspires to bring together clinicians and scientists with diverse expertise and perspectives in cancer research to interact, exchange ideas, and form new collaborations that may lead to new advancements in scientific understanding and ultimately impact patient outcomes.

This year’s conference is dedicated to following sessions:

The IECC 2024 will be an online-only proceeding, which allows participation from all over the world with no requirement for travel or related expenditures. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas.

We are committed to equality and inclusion principles. Therefore, we ask authors to ensure that the papers and presentations are highly accessible to the wider and more diverse scientific community. We encourage submissions from scientists at all career stages and backgrounds and aim for an equal gender balance.

The conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.

We look forward to receiving your contributions to this scientific event and would like to thank you in advance for your active support.

We hope that the community will share this enthusiasm and help make this conference a success.

Sincerely,
Dr. Angeliki Magklara, Dr. Shinji Kawabata, Prof. Dr. Alfredo Conti, Professor Vasso Apostolopoulos
The chair of the 4th International Electronic Conference on Cancers

Welcome to follow us at

Sessions

IECC 2024 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.

Important Deadlines

1. Deadline for abstract submission: 7th November 2023 15th December 2023.
2. Announcement of oral and poster abstract results: 7th December 2023 20th January 2024. You will be notified of the acceptance of an oral/poster presentation in a separate email.

Abstract Submission

Abstract submissions should be completed online by registering with www.sciforum.net and using the "New Submission" function once logged into the system. No physical template is necessary.

1. The abstract should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All accepted abstracts will be published as one dedicated volume (Conference Report) in MDPI’s Proceedings journal (ISSN 2673-9992). If you wish to publish a proceedings paper or a research article in the journal, please refer to the “Publication Opportunities” Section.
3. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
4. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.

Detailed Requirements:

1. Please note that the submitting author will receive all correspondence relating to the abstract. Thus, the submitting author must be the presenting author.
2. The presenting author must ensure that all co-authors are aware of the contents of the abstract.
3. The presenting author must be listed as the first author for this conference.

Note: We only accept live presentations.

Oral Presentation and Slides Submission

The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.

Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format before submission so that they can be converted for online display.

Poster

· Should include the title, authors, contact details, and main research findings, as well as tables, figures, and graphs where necessary.

· File format: PDF (.pdf).

· Size in pixel: 1,080 width x 1,536 height–portrait orientation.

· Size in cm: 38.1 width x 54.2 height–portrait orientation.

· Font size: ≥16.

Examples of successful submissions can be viewed here at the following links: (1), (2), (3)

You can use our free template to create your poster. The poster template can be downloaded here.

The Poster Sessions will take place in Zoom break-out rooms. The rooms will be called after your surname. You will automatically be assigned to your break-out room, however, you will be responsible for your own room, i.e. sharing your screen by yourself, handling the comments in the chat if there are any, etc. People will then be able to visit your room and discuss your poster with you. Please make sure you have the Zoom Desktop client or mobile app, version 5.3.0 or higher.
We will reach out to you closer to the dates of the conference with more information.

Publication Opportunities

1. Cancers Journal Publication

Participants in this conference are cordially invited to contribute a research article to the Special Issue published in Cancers (ISSN: 2072-6694, IF 5.2), with a 20% discount on the publication fee. Please note that no other discounts are applicable. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.

2. Proceeding Paper Publication

You are welcome to submit a proceeding paper (4-8 pages) to Medical Sciences Forum (ISSN: 2673-9992) after the conference.
Publication of the proceedings will be free of charge.
Authors are asked to disclose that it is a proceeding paper of the IECC2024 conference paper in their cover letter.
Proceedings submission deadline: 29 February 2024
Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Manuscripts for the proceedings issue must be formatted as follows:

• Title.
• Full author names.
• Affiliations (including full postal address) and authors' e-mail addresses.
• Abstract.
• Keywords.
• Introduction.
• Methods.
• Results and Discussion.
• Conclusions.
• Acknowledgements.
• References.

proceedings-template.dot

Note : Publication of proceedings paper is free of charge.

Potential Conflicts of Interest

It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

Copyright

MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.

For information regarding sponsorship and exhibition opportunities, please click here.